A detailed history of Peak6 LLC transactions in Gh Research PLC stock. As of the latest transaction made, Peak6 LLC holds 20,000 shares of GHRS stock, worth $262,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Previous 100 19900.0%
Holding current value
$262,200
Previous $1,000 24200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$8.66 - $13.79 $382,884 - $609,697
-44,213 Reduced 68.85%
20,000 $243,000
Q1 2025

May 14, 2025

BUY
$7.91 - $17.99 $39,652 - $90,183
5,013 Added 8.47%
64,213 $708,000
Q4 2024

Feb 13, 2025

BUY
$6.3 - $10.95 $372,960 - $648,240
59,200 New
59,200 $414,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $682M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.